$ANGO News

AngioDynamics Announces Publication of DIRECT Study Results and New Category I CPT Code for Pancreatic IRE

AngioDynamics Reports DIRECT Study Findings Showing Longer Overall Survival In Stage III Pancreatic Ductal Adenocarcinoma, Gets Category I CPT Code For Open IRE Ablation Of Pancreatic Tumors, Effective January 1, 2027

AngioDynamics: Progress Evident, But Volatility And Margin Concerns Persist

HC Wainwright & Co. Maintains Buy on AngioDynamics, Lowers Price Target to $18

ANGO Q1 Earnings Beat Estimates on Med Tech Growth, Revenues Up Y/Y

AngioDynamics (ANGO) Q1 2027 Earnings Call Transcript

AngioDynamics Q1 Earnings Call Highlights

AngioDynamics, Inc. 2027 Q1 - Results - Earnings Call Presentation

AngioDynamics Stock Is Falling Thursday: What's Going On?

AngioDynamics Shares Fall 4.3% Despite Q1 Earnings Beat and Strong Med Tech Growth

AngioDynamics, Inc. (ANGO) Q1 2027 Earnings Call Transcript

AngioDynamics (NASDAQ:ANGO) Posts Narrower Q1 Loss, Holds Guidance Below Consensus

AngioDynamics stock slips 4% despite beating estimates on Med Tech growth

AngioDynamics (ANGO) Reports Q1 Loss, Lags Revenue Estimates

AngioDynamics: Fiscal Q1 Earnings Snapshot

AngioDynamics Reports Fiscal Year 2027 First Quarter Financial Results; Continued Execution Drives Med Tech Growth and Profitability

AngioDynamics Announces Appointment of Eric Honroth as President and Chief Executive Officer

AngioDynamics Q1 2027 Earnings Call: Complete Transcript

AngioDynamics Appoints Eric Honroth As President And CEO, Effective November 2

AngioDynamics Affirms FY2027 Adj EPS Guidance of $(0.29)-$(0.24) vs $(0.27) Est; Affirms FY2027 Sales Guidance of $336.000M-$341.000M vs $337.400M Est